Benjamin Kornitzer - 15 Mar 2023 Form 4 Insider Report for agilon health, inc. (AGL)

Signature
/s/ Steve Meetre, as Attorney-in-Fact
Issuer symbol
AGL
Transactions as of
15 Mar 2023
Net transactions value
-$860,424
Form type
4
Filing time
17 Mar 2023, 16:55:15 UTC
Previous filing
09 Mar 2023
Next filing
24 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Options Exercise $449,000 +100,000 +959% $4.49* 110,426 15 Mar 2023 Direct F1
transaction AGL Common Stock Sale $1,309,424 -55,000 -50% $23.81 55,426 15 Mar 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Rights to Buy) Options Exercise $0 -100,000 -36% $0.000000 175,000 15 Mar 2023 Common Stock 100,000 $4.49 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes restricted stock units.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.465 to $24.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F3 These options were granted on January 31, 2020 and vest in four equal installments on January 31 of each of 2021, 2022, 2023, and 2024.